Key realise investment in home health testing business
Key Capital Partners (“Key”) has successfully exited their investment in home health testing business YorkTest Laboratories Limited (“YorkTest”) in a secondary buyout by NVM Private Equity. The transaction provides Key with its fifth successful exit from Fund VIII.
YorkTest is a leading health and wellness company with over 40 years of scientific expertise in the provision of home-to-laboratory tests in the UK and US, with an historic focus on food intolerance and allergy testing. The company has grown its revenues significantly over recent years, supported by Key’s investment, and is well positioned to continue its growth trajectory under new ownership.
Richard Dawson, CEO of YorkTest said: “Key has been an understanding and supportive partner; I’ve really enjoyed working with them.”
Matt Tice, Director at Key commented: “Having supported the business over the past five years, we are pleased to see YorkTest transition to new ownership and wish the management team and new owners every success for the business going forwards. This transaction provides Key with another successful exit for a highly performing fund.”
Key and the management shareholders were advised on the transaction by John Hamer, Sam Bellagha and Amy Walton of Walker Morris, whilst management advice was provided by Jonathan Pollard of Ward Hadaway.
Key makes equity investments of between £3m and £15m and has a strong reputation of deliverability and a track record of producing outstanding returns for its investors. Other current investments by the firm include Commhoist, Total Integrated Solutions and Jellyfish Pictures.